» Articles » PMID: 19601712

Direct Association of Thioredoxin-1 (TRX) with Macrophage Migration Inhibitory Factor (MIF): Regulatory Role of TRX on MIF Internalization and Signaling

Overview
Specialty Endocrinology
Date 2009 Jul 16
PMID 19601712
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Thioredoxin-1 (TRX) is a small (14 kDa) multifunctional protein with the redox-active site Cys-Gly-Pro-Cys. Macrophage migration inhibitory factor (MIF) is a 12 kDa cytokine belonging to the TRX family. Historically, when we purified TRX from the supernatant of ATL-2 cells, a 12 kDa protein was identified along with TRX, which was later proved to be MIF. Here, we show that TRX and MIF form a complex in the cell and the culture supernatant of ATL-2 cells. Using a BIAcore assay, we confirmed that TRX has a specific affinity with MIF. We also found that extracellular MIF was more effectively internalized into the ATL-2 cells expressing TRX on the cell surface, than the Jurkat T cells which do not express surface TRX. Moreover, anti-TRX antibody blocked the MIF internalization, suggesting that the cell surface TRX is involved in MIF internalization into the cells. Furthermore, anti-TRX antibody inhibited MIF-mediated enhancement of TNF-alpha production from macrophage RAW264.7 cells. These results suggest that the cell surface TRX serves as one of the MIF binding molecules or MIF receptor component and inhibits MIF-mediated inflammatory signals.

Citing Articles

TXM-CB13 Improves the Intestinal Mucosal Barrier and Alleviates Colitis by Inhibiting the ROS/TXNIP/TRX/NLRP3 and TLR4/MyD88/NF-κB/NLRP3 Pathways.

Cao R, Zhou J, Liu J, Wang Y, Dai Y, Jiang Y Inflammation. 2025; .

PMID: 40085192 DOI: 10.1007/s10753-025-02282-9.


Redox regulation of the immune response.

Morris G, Gevezova M, Sarafian V, Maes M Cell Mol Immunol. 2022; 19(10):1079-1101.

PMID: 36056148 PMC: 9508259. DOI: 10.1038/s41423-022-00902-0.


Thioredoxin-1 Ameliorates Oxygen-Induced Retinopathy in Newborn Mice through Modulation of Proinflammatory and Angiogenic Factors.

Ozawa J, Tanaka K, Arai Y, Haga M, Miyahara N, Miyamoto A Antioxidants (Basel). 2022; 11(5).

PMID: 35624763 PMC: 9137876. DOI: 10.3390/antiox11050899.


Thioredoxin-1: A Promising Target for the Treatment of Allergic Diseases.

Wang J, Zhou J, Wang C, Fukunaga A, Li S, Yodoi J Front Immunol. 2022; 13:883116.

PMID: 35572600 PMC: 9095844. DOI: 10.3389/fimmu.2022.883116.


Long-Acting Thioredoxin Ameliorates Doxorubicin-Induced Cardiomyopathy via Its Anti-Oxidative and Anti-Inflammatory Action.

Murata R, Watanabe H, Nosaki H, Nishida K, Maeda H, Nishida M Pharmaceutics. 2022; 14(3).

PMID: 35335938 PMC: 8953310. DOI: 10.3390/pharmaceutics14030562.